Venrock Adviser, LLC Diversified Active

Location: New York, NY

CIK: 0001615982 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value: $508M (100.0% shares, 0.0% debt)

Holdings (27)

Tricida Inc 13.6%
Value $69.04M Shares 7,132,079 Est. Cost $9.15 Unrealized
ACRS Aclaris Therapeutics Inc 12.5%
Value $63.71M Shares 4,563,962 Est. Cost $13.57 Unrealized +3.3%
RLMD Relmada Therapeutics Inc 8.5%
Value $43.11M Shares 2,270,072 Est. Cost $31.54 Unrealized -30.8%
TVTX Travere Therapeutics Inc 8.2%
Value $41.46M Shares 1,711,102 Est. Cost $19.66 Unrealized +27.9%
COGT Cogent Biosciences Inc 7.2%
Value $36.42M Shares 4,038,117 Est. Cost $7.95 Unrealized -14.1%
GHRS GH Research PLC 6.3%
Value $31.79M Shares 3,185,573 Est. Cost $17.93 Unrealized -27.5%
Instil Bio Inc 5.5%
Value $27.71M Shares 5,997,657 Est. Cost $25.08 Unrealized
CLDX Celldex Therapeutics Inc 4.6%
Value $23.32M Shares 865,116 Est. Cost $15.71 Unrealized +84.9%
VRDN Viridian Therapeutics Inc 4.2%
Value $21.44M Shares 1,852,919 Est. Cost $18.59 Unrealized -27.7%
VistaGen Therapeutics Inc 3.6%
Value $18.21M Shares 20,697,286 Est. Cost $1.76 Unrealized
Marinus Pharmaceuticals Inc 3.0%
Value $15.28M Shares 3,156,803 Est. Cost $11.98 Unrealized
WHWK Aadi Bioscience Inc 2.8%
Value $14.46M Shares 1,173,518 Est. Cost $30.48 Unrealized -51.3%
Inozyme Pharma Inc 2.5%
Value $12.93M Shares 2,709,987 Est. Cost $4.77 Unrealized
Akouos Inc 2.5%
Value $12.51M Shares 2,667,119 Est. Cost $4.69 Unrealized
LIANY LianBio 2.3%
Value $11.62M Shares 5,378,341 Est. Cost $6.16 Unrealized
Aerovate Therapeutics Inc 1.8%
Value $9.228M Shares 590,408 Est. Cost $16.32 Unrealized
TRVI Trevi Therapeutics Inc 1.7%
Value $8.571M Shares 3,050,022 Est. Cost $2.46 Unrealized 0.0%
Chinook Therapeutics Inc 1.7%
Value $8.563M Shares 489,618 Est. Cost $16.31 Unrealized
ANNX Annexon Inc 1.4%
Value $7.27M Shares 1,928,477 Est. Cost $3.06 Unrealized 0.0%
SVRA Savara Inc 1.2%
Value $6.259M Shares 4,117,530 Est. Cost $1.26 Unrealized +4.0%
Lyra Therapeutics Inc 1.0%
Value $5.222M Shares 924,170 Est. Cost $5.65 Unrealized
Provention Bio Inc 0.9%
Value $4.475M Shares 1,118,653 Est. Cost $7.32 Unrealized
ALT Altimmune Inc 0.9%
Value $4.321M Shares 369,306 Est. Cost $7.36 Unrealized -16.3%
ATYR aTyr Pharma Inc 0.8%
Value $3.959M Shares 1,398,889 Est. Cost $5.98 Unrealized -39.6%
Affimed NV 0.8%
Value $3.957M Shares 1,428,571 Est. Cost $5.52 Unrealized
Rallybio Corp 0.4%
Value $2.027M Shares 268,532 Est. Cost $7.55 Unrealized
XENE Xenon Pharmaceuticals Inc 0.2%
Value $913K Shares 30,000 Est. Cost $30.24 Unrealized 0.0%